Clarivate PLC (CLVT): Price and Financial Metrics

Clarivate PLC (CLVT): $14.00

0.14 (+1.01%)

POWR Rating

Component Grades














  • CLVT scores best on the Growth dimension, with a Growth rank ahead of 87.6% of US stocks.
  • The strongest trend for CLVT is in Stability, which has been heading down over the past 179 days.
  • CLVT ranks lowest in Quality; there it ranks in the 1st percentile.

CLVT Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CLVT is 0.16 -- better than merely 14.41% of US stocks.
  • CLARIVATE Plc's stock had its IPO on September 7, 2018, making it an older stock than merely 11.81% of US equities in our set.
  • The price/operating cash flow metric for CLARIVATE Plc is higher than 85.16% of stocks in our set with a positive cash flow.
  • Stocks that are quantitatively similar to CLVT, based on their financial statements, market capitalization, and price volatility, are UHAL, DPZ, NWE, AR, and RYAAY.
  • Visit CLVT's SEC page to see the company's official filings. To visit the company's web site, go to

CLVT Valuation Summary

  • CLVT's price/sales ratio is 10.3; this is 94.34% higher than that of the median Technology stock.
  • Over the past 36 months, CLVT's price/sales ratio has gone up 9.5.
  • Over the past 36 months, CLVT's price/sales ratio has gone up 9.5.

Below are key valuation metrics over time for CLVT.

Stock Date P/S P/B P/E EV/EBIT
CLVT 2021-09-01 10.3 1.4 -58.0 -119.0
CLVT 2021-08-31 10.0 1.4 -56.3 -115.7
CLVT 2021-08-30 10.0 1.4 -56.0 -115.1
CLVT 2021-08-27 9.9 1.4 -55.9 -114.9
CLVT 2021-08-26 9.9 1.4 -55.8 -114.6
CLVT 2021-08-25 9.8 1.4 -55.3 -113.8

CLVT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLVT has a Quality Grade of F, ranking ahead of 3.32% of graded US stocks.
  • CLVT's asset turnover comes in at 0.104 -- ranking 521st of 563 Business Services stocks.
  • 500 - Internal server error

The table below shows CLVT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.104 0.672 -0.013
2021-06-30 0.118 0.671 -0.050
2021-03-31 0.142 0.663 -0.039
2020-12-31 0.164 0.682 0.001
2019-12-31 0.434 0.644 -0.037

CLVT Price Target

For more insight on analysts targets of CLVT, see our CLVT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $34.00 Average Broker Recommendation 1.42 (Moderate Buy)

CLVT Stock Price Chart Interactive Chart >

Price chart for CLVT

CLVT Price/Volume Stats

Current price $14.00 52-week high $27.28
Prev. close $13.86 52-week low $11.71
Day low $13.49 Volume 4,097,400
Day high $14.03 Avg. volume 5,748,563
50-day MA $14.50 Dividend yield N/A
200-day MA $18.52 Market Cap 9.42B

Clarivate PLC (CLVT) Company Bio

Clarivate Plc engages in the provision of trusted insights and analytics to accelerate the pace of innovation. It operates through the Science and Intellectual Property segments. The Science segment comprises the academic and life science product lines. The Intellectual Property segment includes patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London.

CLVT Latest News Stream

Event/Time News Detail
Loading, please wait...

CLVT Latest Social Stream

Loading social stream, please wait...

View Full CLVT Social Stream

Latest CLVT News From Around the Web

Below are the latest news stories about CLARIVATE Plc that investors may wish to consider to help them evaluate CLVT as an investment opportunity.

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Clarivate Plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CLVT

NEW YORK, Feb. 23, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Clarivate Plc (NYSE: CLVT) between February 26, 2021 and December 27, 2021, inclusive (the "Class Period"), of the important March 25, 2022 lead…

PR Newswire | February 23, 2022

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FirstCash, NRx, Clarivate, and Bumble and Encourages Investors to Contact the Firm

NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of FirstCash Holdings, Inc. (NASDAQ: FCFS), NRx Pharmaceuticals, Inc. (NASDAQ: NRXP, NRXPW), Clarivate Plc (NYSE: CLVT), and Bumble, Inc. (NASDAQ: BMBL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

GlobeNewswire | February 23, 2022

Asia Extends Dominance in Global Innovation Ecosystem, Signals New Era for Innovation, Reveals Top 100 Global Innovators 2022 from Clarivate

Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the Top 100 Global Innovators™ 2022 list. Drawing on Clarivate™ data, the annual list identifies the organizations that demonstrate consistent, above-the-bar innovation excellence and which sit at the very top of the global innovation ecosystem.

Yahoo | February 23, 2022

CLARIVATE PLC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on March 25, 2022 in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Clarivate Plc (“Clarivate”) ( NYSE: CLVT; CLVT-PA ). The action charges Clarivate with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Clarivate’s materially misleading statements to the public, Clarivate investors have suffered significant losses.

GlobeNewswire | February 18, 2022

BioWorld by Clarivate Provides In-depth Analyses of Long COVID Studies, Potentially the Next Public Health Crisis

BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has announced new analysis tracking the latest developments related to the study of long COVID-19, a complex syndrome affecting more than 100 million people globally. BioWorld is a suite of award-winning news services delivering actionable intelligence on the most innovative therapeutics and medical technologies in development. The analysis zeroes i

Yahoo | February 17, 2022

Read More 'CLVT' Stories Here

CLVT Price Returns

1-mo -4.70%
3-mo -15.66%
6-mo -39.55%
1-year -48.21%
3-year N/A
5-year N/A
YTD -40.48%
2021 -20.83%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6896 seconds.